|
|
|
|
|
Bhardy
|
Innovation in Life Science & Healthcare
Research & Product Development | | InnovationWell Community of Practice InterAction Meeting, Autumn 2008
Bryn Mawr College, Philadelphia (14-17 October 2008) | | Themes: Critical Path Advances in Drug Development, Innovation & Knowledge Management in R&D and Translational Medicine, Computational Biology, Predictive ADME, Predictive Toxicology, Metabolomics, Biomarkers, Systems Biology |
Conference Sessions and Chairs:
Pre-Conference Workshop on KM in R&D, chaired by John Conway (Accelrys) and Frank Hollinger (FRESH Directions Consulting)
Systems Biology, chaired by Keith Elliston (Genstruct)
Computational Biology, chaired by Debraj Guhathakurta (Merck)
Knowledge Management in Translational Medicine, David Bousfield (Ganesha Associates)
Applications of Metabolomics to Drug Discovery & Development, chaired by Bruce Kristal (Brigham and Women’s Hospital)
Predictive ADME, chaired by Anthony E. Klon (Pharmacopeia Drug Discovery)
Predictive Toxicology, chaired by Artem Cherkasov (University of British Columbia)
Confirmed Invited Speakers: Keith Elliston (Genstruct), Debraj GuhaThakurta (Rosetta Inpharmatics, Merck & Co.), Stephen W. Edwards (U.S. Environmental Protection Agency), Paul McDonagh (Gene Network Sciences), Christopher M.L.S. Bouton (Pfizer), James R. Brown (GlaxoSmithKline), John Wilbanks (Creative Commons), Barry Bunin (Collaborative Drug Discovery), Michael Liebman (Strategic Medicine, Inc.), Jerry Wright (Johns Hopkins Medical Institutions), Anastasia Christianson (AstraZeneca), James Golden (Science Applications International Corporation), John Speakman (National Cancer Institute), William Hayes (Biogen Idec), Andrew McMurry (Harvard Medical School), Eugene Clark (Partners Healthcare), Alvin Berger (Metabolon), John Newman (USDA), Bruce Kristal (Brigham and Women’s Hospital), Pierre Beauparlant (Gemin X Pharmaceuticals Inc.), Mark Sanders (Thermo Fisher Scientific), Anton Hopfinger (University of New Mexico), Heidi Einolf (Novartis), Yojiro Sakiyama (Pfizer), Olga Obrezanova (BioFocus DPI, UK), Anthony E. Klon (Pharmacopeia), Artem Cherkasov (University of British Columbia, Canada), Ann Richards (US EPA), Curt Breneman (RPI), Alex Tropsha (UNC), Barry Hardy (Douglas Connect), Weida Tong (FDA), Frank Brown (Accelrys), Chris Culberson (Merck Research Laboratories), Tim McIntyre (GlaxoSmithKline), Ralph T. Mosley (Pharmasset), Chris Smith (Pfizer)
Format: Seminars, Roundtables, Presentations, Panel Q&As, Discussions, Break-out Workshops, Web-supported. Evening Poster sessions, networking, social activities.
Conference Program and Schedule...
Pre-Conference Workshop: Advances in Knowledge Management in R&D...
Location Information...
Call for Contributions...
Bursary Awards...
Poster Session...
Sponsors & Exhibitors...
|
|
|
Registration
Online Conference Registration involves two steps:
1. Complete the Signup form to signup or access the Web site (no charge involved)
2. Once logged into the Web site please use the Online Ticket Office to complete a registration order, to make a secure payment by credit card or to request an invoice.
You may also contact us directly by email, phone, fax or mail:
Email: innovationwell [at] douglasconnect.com
Phone: +41 61 851 04 61 or +41 61 851 01 70
Fax: +44 870 112 38 44
Mail: Douglas Connect, Baermeggenweg 14, CH - 4314 Zeiningen, Switzerland
|
|
|
|
|
|
|
